The recent announcement of the upcoming potential merger of Rite Aid and Albertsons is driving new discussions around
the evolution of consumers and shoppers across the drug and grocery channels. Retail consumer behavior is changing
due to social media influence and the shift to a more convenient, dynamic purchase landscape. Both the drug and grocery
channels are impacted by these changes, making it even more important for Albertsons to be aware of the opportunities
and challenges ahead. This session will take a closer look at:
- The factors that are driving disruption at retail
- Challenges in the drug channel
Robert Sanders, EVP, Home & Healthcare Practice Leader, IR
Robert (Bob) Sanders brings more than 30 years of experience to the marketplace and is responsible for cultivating and
building global partnerships with IRI’s clients. In his current role, Bob sets the strategic initiatives for IRI’s home and
healthcare practice by identifying business opportunities, delivering insights and making actionable recommendations
critical for winning in the market. He leads teams of seasoned insights and consulting professionals with extensive
expertise in CPG/HBA, Nutritionals and home-related categories.
Bob is a senior executive with a strong general management and consultative background. Before joining IRI in 2008, he
held executive positions with Wyeth/Pfizer Whitehall-Robins and Lederle Consumer Health in sales, marketing and
general management capacities. As the senior vice president of Sales at Wyeth, he managed direct, broker and medical
sales teams. As SVP/General Manager for nine years focused on developing global brand strategies, Bob and his team
drove sales, share and profitability growth year over year.
Bob graduated from William Paterson University and has an MBA from the University of Scranton. He also holds a
certificate from the Columbia Executive Program and is a Certified Public Accountant (CPA).